Phagos
Business Services · France · 11-50 Employees
View Company Info for Free
Overview
Headquarters
5 Rue Gardenat Lapostol, Suresnes, Ile-d...Website
www.phagos.comRevenue
$10.6 MillionIndustry
About Phagos
Is Phagos your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Phagos has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Phagos recently announced quarterly report
Funding: Get notified immidiatlly once Phagos has new funding data
Congratulate Masked Content for being promoted to Masked Content at Phagos
Website visits: Recent activity has been detected on your website
Click to see if Phagos had a recent Job posting/layoffs
Phagos, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Phagos launches new products
Check out if Phagos is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined Phagos as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Phagos is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Phagos is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Phagos.
Phagos financials insights
Gather financial insights about Phagos, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Series A
$29M
Phagos Tech Stack
A closer look at the technologies used by Phagos
Most Recent Scoops
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Phagos
Phagos specializes in developing customizable medicines that leverage the evolutionary potential of bacteriophages to combat antibiotic-resistant bacteria. Their innovative approach allows for the rapid development of new cures, achieving results in as little as two months. The company aims to address the global health threat posed by antimicrobial... Read More